These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20166112)

  • 21. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations].
    Takahashi N; Morita M; Imanaka T
    Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
    Baarine M; Beeson C; Singh A; Singh I
    J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters.
    van Roermund CW; Visser WF; Ijlst L; van Cruchten A; Boek M; Kulik W; Waterham HR; Wanders RJ
    FASEB J; 2008 Dec; 22(12):4201-8. PubMed ID: 18757502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
    Kruska N; Schönfeld P; Pujol A; Reiser G
    Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.
    Corzo D; Gibson W; Johnson K; Mitchell G; LePage G; Cox GF; Casey R; Zeiss C; Tyson H; Cutting GR; Raymond GV; Smith KD; Watkins PA; Moser AB; Moser HW; Steinberg SJ
    Am J Hum Genet; 2002 Jun; 70(6):1520-31. PubMed ID: 11992258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of peroxisomal lipid metabolism in mice fed a high-fat diet.
    Kozawa S; Honda A; Kajiwara N; Takemoto Y; Nagase T; Nikami H; Okano Y; Nakashima S; Shimozawa N
    Mol Med Rep; 2011; 4(6):1157-62. PubMed ID: 21850377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy.
    Heinzer AK; Watkins PA; Lu JF; Kemp S; Moser AB; Li YY; Mihalik S; Powers JM; Smith KD
    Hum Mol Genet; 2003 May; 12(10):1145-54. PubMed ID: 12719378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy.
    Feigenbaum V; Lombard-Platet G; Guidoux S; Sarde CO; Mandel JL; Aubourg P
    Am J Hum Genet; 1996 Jun; 58(6):1135-44. PubMed ID: 8651290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid.
    Sassa T; Wakashima T; Ohno Y; Kihara A
    J Lipid Res; 2014 Mar; 55(3):524-30. PubMed ID: 24489110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
    Kemp S; Wanders RJ
    Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
    Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
    Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing substrate-induced conformational alterations in adrenoleukodystrophy protein by proteolysis.
    Guimarães CP; Sá-Miranda C; Azevedo JE
    J Hum Genet; 2005; 50(2):99-105. PubMed ID: 15682271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
    Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol-deprivation increases mono-unsaturated very long-chain fatty acids in skin fibroblasts from patients with X-linked adrenoleukodystrophy.
    Engelen M; Ofman R; Mooijer PA; Poll-The BT; Wanders RJ; Kemp S
    Biochim Biophys Acta; 2008 Mar; 1781(3):105-11. PubMed ID: 18206987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy.
    Rattay TW; Rautenberg M; Söhn AS; Hengel H; Traschütz A; Röben B; Hayer SN; Schüle R; Wiethoff S; Zeltner L; Haack TB; Cegan A; Schöls L; Schleicher E; Peter A
    Sci Rep; 2020 Sep; 10(1):15093. PubMed ID: 32934269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.
    Braiterman LT; Zheng S; Watkins PA; Geraghty MT; Johnson G; McGuinness MC; Moser AB; Smith KD
    Hum Mol Genet; 1998 Feb; 7(2):239-47. PubMed ID: 9425230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters.
    Liu LX; Janvier K; Berteaux-Lecellier V; Cartier N; Benarous R; Aubourg P
    J Biol Chem; 1999 Nov; 274(46):32738-43. PubMed ID: 10551832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
    Monternier PA; Singh J; Parasar P; Theurey P; DeWitt S; Jacques V; Klett E; Kaur N; Nagaraja TN; Moller DE; Hallakou-Bozec S
    J Inherit Metab Dis; 2022 Jul; 45(4):832-847. PubMed ID: 35510808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.